- You are here:
- Home »
- Blog
Hemorrhagic Cystitis, Bladder Cancer
“Cyclophosphamide increases the risk of developing some kinds of bladder cancers and Hemorrhagic Cystitis, which can occur years after taking this medication…Bladder cancer is the most common
Continue readingLymphoma-“Risk of Secondary Cancer”
“…but the investigators wrote that this study confirmed the continual risk of secondary cancer beyond 25 years after a diagnosis of Hodgkin lymphoma…” The study isn’t talking
Continue readingSecondary Cancer – Multiple Myeloma
“Pediatric and AYA cancer survivors remain at increased risk for treatment-related subsequent neoplasms, even after the age of 40, according to a new study published online ahead of print in the
Continue readingMyeloma Stem Cell Transplant- ASCT Exercise PreHabilitation
“Patients with myeloma undergoing autologous SCT (ASCT) experience treatment-related morbidity and reduction in function and well-being for many months post-treatment.” Granted, the first study
Continue readingMultiple Myeloma Pain
Multiple Myeloma Bone, Nerve, Joint and Muscle Pain Can be Controlled I am a long-term myeloma survivor and myeloma cancer coach. Have you heard the Groucho Marx joke that he wouldn’t want to join
Continue readingSaw Palmetto- Kill Multiple Myeloma, Urinate, Sleep Better-
These results indicate that Serenoa repens (saw palmetto) might be useful for the treatment of individuals with multiple myeloma.” I turned 60 last December. I’ve taken saw palmetto off and
Continue readingAnticipate,Treat Difficulty Swallowing- Dysphagia
Dysphagia increased by 11.7% over the 10‐year period. Prevalence was highest after chemoradiation and multimodality therapy. I am not a H & N cancer survivor. I am a survivor of a blood cancer called
Continue reading40% of Seniors A-fib- Reduce Risk of Stroke W/ Non-Toxic Therapy
“By 30 months, 40 percent of patients were determined to have suffered at least one episode of this type of abnormal rhythm (A-fib)…” If you take away only two pieces of information from
Continue readingGradual vs. Fast Response in Myeloma?
“The five-year survival rate was 77 percent for (myeloma) patients who achieved their best response to initial treatment in more than 120 days, and 56 percent for patients who achieved their best
Continue readingChemo-Induced A Fib- Non-Toxic Therapy
“(Chemo-induced) Atrial fibrillation, often called AFib or AF, is the most common type of treated heart arrhythmia. An arrhythmia is when the heart beats too slowly, too fast, or in an irregular
Continue readingMyeloma Chemotherapy- Proteasome Inhibitors
“More importantly, a low concentration of RSV was synergistic with a low dose of the proteasome inhibitor carfilzomib (CFZ) to induce apoptosis in myeloma cells… Bortezomib (velcade), Carfilzomib
Continue readingMyeloma – Non-toxic Bone Health
“Supportive care targeting bone disease is an essential adjunct to antimyeloma therapy. In addition, the maintenance of bone health in patients with multiple myeloma can significantly improve…” According
Continue reading